1. Secretion of IL-1β triggered by dynasore in murine peritoneal macrophages.
- Author
-
Seil M, El Ouaaliti M, and Dehaye JP
- Subjects
- Adenosine Triphosphate pharmacology, Animals, Calcium metabolism, Caspase 1 metabolism, Cells, Cultured, Coloring Agents, L-Lactate Dehydrogenase metabolism, Macrophages, Peritoneal drug effects, Male, Mice, Mice, Knockout, Potassium metabolism, Receptors, Purinergic P2X4 metabolism, Receptors, Purinergic P2X7 genetics, Tetrazolium Salts, Thiazoles, Hydrazones pharmacology, Interleukin-1beta metabolism, Macrophages, Peritoneal metabolism
- Abstract
The interaction of lipopolysaccharide-primed murine peritoneal macrophages with ivermectin, an antiparasite drug which potentiates P2X(4) receptors and dynasore which inhibits the GTPase activity of dynamin, a protein contributing to the internalization of plasma membrane proteins, was tested. Murine peritoneal macrophages express P2X(4) receptors which are mostly intracellular. In cells from P2X(7)-knockout mice (KO mice), 10 µm adenosine triphosphate (ATP) provoked a transient increase of the intracellular concentration of calcium. Ivermectin had no effect by itself but potentiated the increase of the intracellular concentration of calcium by ATP. The combination of ATP plus ivermectin also decreased the intracellular concentration of potassium and promoted the secretion of IL-1β. Concentrations of dynasore above 50 µm affected the integrity of mitochondria (MTT test) and of the plasma membrane (release of lactate dehydrogenase, LDH). At a 10 µm concentration, dynasore had no effect on the responses to ATP and on the internalization of P2X(4) receptors. By itself dynasore promoted the release of potassium and the secretion of IL-1β after activation of caspase-1. In conclusion, our results confirm that ivermectin potentiates the responses coupled to P2X(4) receptors probably by interaction with an allosteric site. We also show that this potentiation triggers the release of IL-1β by macrophages. As opposed to ivermectin, dynasore has no effect on P2X(4) receptors. This drug triggers a potassium efflux via a mechanism which does not involve purinergic receptors and generates, in consequence, the activation of caspase-1 and the secretion of IL-1β.
- Published
- 2012
- Full Text
- View/download PDF